Recent 8-K filings for HBIO

Each filing is summarized by an LLM — headline, three bullets, event type. The source document on EDGAR is one click away. See methodology.

• May 12, 2026 11:30 UTC other item 7.01item 9.01

  Harvard Bioscience furnishes May 2026 investor presentation with no material new data

• May 12, 2026 11:30 UTC earnings item 2.02item 9.01

  Harvard Bioscience Q1 revenue $20.8M, gross margin 59%; reaffirms FY guidance

source · HBIO on sec.gov